Back

Tocolytic Drugs

Tocolytic drugs relax the uterus to delay preterm birth. They do not prevent preterm birth or improve outcomes on their own, but a delay of 48 hours allows antenatal corticosteroids to work, magnesium sulfate for neuroprotection to be given, and transfer to a unit with neonatal care. Nifedipine, atosiban and indomethacin are the main drugs.

Classification. Calcium channel blocker (nifedipine); oxytocin receptor antagonist (atosiban); cyclo-oxygenase inhibitor (indomethacin); beta-2 agonists (terbutaline, salbutamol, ritodrine) with more maternal harm; magnesium sulfate (not an effective tocolytic, used for neuroprotection).

Mechanism. Nifedipine blocks calcium entry into myometrial cells. Atosiban blocks oxytocin receptors. Indomethacin inhibits prostaglandin synthesis. Beta-2 agonists raise cyclic AMP.

Pharmacokinetics. Nifedipine is absorbed orally within 30 to 60 minutes; half-life 2 to 5 hours. Atosiban is intravenous with a half-life of about 1.7 hours. Indomethacin is given orally or rectally, crosses the placenta and shuts the ductus arteriosus.

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

On the evidence

Doses are traceable.

Management sections cite the guideline they came from. Atlas supports clinical judgement rather than replacing it; verify against current national guidance and the patient in front of you.

Learn it.
Know it.
Own it.